Atrial fibrillation affects almost 60 million adults worldwide. Atrial fibrillation is associated with a high risk of cardiovascular morbidity and death as well as with social, psychological and economic burdens on patients and their families. Social determinants — such as race and ethnicity, financial resources, social support, access to health care, rurality and residential environment, local language proficiency and health literacy — have prominent roles in the evaluation, treatment and management of atrial fibrillation. Addressing the social determinants of health provides a crucial opportunity to reduce the substantial clinical and non-clinical complications associated with atrial fibrillation. In this Review, we summarize the contributions of social determinants to the patient experience and outcomes associated with this common condition. We emphasize the relevance of social determinants and their important intersection with atrial fibrillation treatment and outcomes. In closing, we identify gaps in the literature and propose future directions for the investigation of social determinants and atrial fibrillation.
Atrial fibrillation is the most common cardiac rhythm disorder, affecting nearly 60 million adults worldwide, and is associated with substantial morbidity and mortality.
Social determinants, such as race/ethnicity, financial resources, social support, rurality and residential environment, and health literacy, have crucial roles in the detection, evaluation, treatment and management of atrial fibrillation.
Despite their fundamental importance, to date, critical evaluation of the social determinants of health in relation to atrial fibrillation has been limited.
Collecting, studying and addressing social determinants of health provides an important opportunity to reduce the substantial social and economic burden of atrial fibrillation and its associated complications.
Important areas for future research include an examination of the intersectional influence of multiple social determinants of health on disadvantaged populations with atrial fibrillation and implementation strategies to eliminate health-care inequities.
Your institute does not have access to this article
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J. Am. Cardiol. 76, 2982–3021 (2020).
Lippi, G., Sanchis-Gomar, F. & Cervellin, G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int. J. Stroke. 16, 217–221 (2021).
Kornej, J., Börschel, C. S., Benjamin, E. J. & Schnabel, R. B. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ. Res. 127, 4–20 (2020).
Marmot, M., Friel, S., Bell, R., Houweling, T. A. & Taylor, S. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 372, 1661–1669 (2008).
Havranek, E. P. et al. Social determinants of risk and outcomes for cardiovascular disease. Circulation. 132, 873–898 (2015).
Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (National Academies Press, 2003).
Williams, D. R. & Mohammed, S. A. Discrimination and racial disparities in health: evidence and needed research. J. Behav. Med. 32, 20–47 (2009).
Williams, D. R. & Cooper, L. A. COVID-19 and health equity–a new kind of “herd immunity”. JAMA 323, 2478–2480 (2020).
Jones, C. P. Toward the science and practice of anti-racism: launching a national campaign against racism. Ethn. Dis. 28, 231–234 (2018).
Essien, U. R. et al. Association of race/ethnicity with oral anticoagulant use in patients with atrial fibrillation. JAMA Cardiol. 3, 1174–1182 (2018).
Essien, U. R. et al. Race/ethnicity and sex-related differences in direct oral anticoagulant initiation in newly diagnosed atrial fibrillation: a retrospective study of Medicare data. J. Natl Med. Assoc. 112, 103–108 (2020).
Magnani, J. W. et al. Racial differences in atrial fibrillation-related cardiovascular disease and mortality: the Atherosclerosis Risk in Communities (ARIC) study. JAMA Cardiol. 1, 433–441 (2016).
Van Dyke, M. et al. Heart disease death rates among blacks and whites aged ≥35 years – United States, 1968–2015. MMWR Surveill. Summ. 67, 1–11 (2018).
Ugowe, F. E., Jackson, L. R. & Thomas, K. L. Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: a systematic review. Heart Rhythm. 15, 1337–1345 (2018).
Nanda, A. & Kabra, R. Racial differences in atrial fibrillation epidemiology, management, and outcomes. Curr. Treat. Options Cardiovasc. Med. 21, 85 (2019).
Linares, J. D. et al. Prevalence of atrial fibrillation and association with clinical, sociocultural, and ancestral correlates among Hispanic/Latinos: the Hispanic Community Health Study/Study of Latinos. Heart Rhythm. 16, 686–693 (2019).
Staerk, L., Sherer, J. A., Ko, D., Benjamin, E. J. & Helm, R. H. Atrial fibrillation: epidemiology, pathophysiology, clinical outcomes. Circ. Res. 120, 1501–1517 (2017).
Sanchez, J. M. et al. Incident atrial fibrillation among American Indians in California. Circulation. 140, 1605–1606 (2019).
Dewland, T. A., Olgin, J. E., Vittinghoff, E. & Marcus, G. M. Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation 128, 2470–2477 (2013).
Mou, L. et al. Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC Study (Atherosclerosis Risk in Communities). Circ. Arrhythmia Electrophysiol. 11, e006350 (2018).
Loehr, L. R. et al. The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to Whites: the Atherosclerosis Risk in Communities (ARIC) study. Am. Heart J. 216, 1–8 (2019).
Chen, M. L. et al. Risk of atrial fibrillation in black versus white Medicare beneficiaries with implanted cardiac devices. J. Am. Heart Assoc. 8, e010661 (2019).
Rodriguez, C. J. et al. Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann. Epidemiol. 25, 71–76 (2015).
Soliman, E. Z., Alonso, A. & Goff, D. C. Atrial fibrillation and ethnicity: the known, the unknown and the paradox. Future Cardiol. 5, 547–556 (2009).
Marcus, G. M. et al. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation. 122, 2009–2015 (2010).
Christensen, M. A. et al. Atrial ectopy as a mediator of the association between race and atrial fibrillation. Heart Rhythm. 14, 1856–1861 (2017).
Meschia, J. F. et al. Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke. 41, 581–587 (2010).
Heckbert, S. R. et al. Differences by race/ethnicity in the prevalence of clinically detected and monitor-detected atrial fibrillation: MESA. Circ. Arrhythm. Electrophysiol. 13, e007698 (2020).
Di Pasquale, G. & Casella, G. Antithrombotic strategies for atrial fibrillation: on the threshold of changes? Yes. J. Thromb. Haemost. 3, 428–432 (2005).
Shen, A. Y.-J. et al. Racial/ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation. Stroke 39, 2736–2743 (2008).
Hellyer, J. A. et al. Impact of baseline stroke risk and bleeding risk on warfarin international normalized ratio control in atrial fibrillation (from the TREAT-AF study). Am. J. Cardiol. 119, 268–274 (2016).
Rao, S. R. et al. Explaining racial disparities in anticoagulation control: results from a study of patients at the Veterans Administration. Am. J. Med. Qual. 30, 214–222 (2015).
Rodwin, B. A. et al. Variation in the use of warfarin and direct oral anticoagulants in atrial fibrillation and associated cost implications. Am. J. Med. 132, 61–70 (2019).
Bhave, P. D., Lu, X., Girotra, S., Kamel, H. & Vaughan Sarrazin, M. S. Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm. 12, 1406–1412 (2015).
Razouki, Z., Ozonoff, A., Zhao, S. & Rose, A. J. Pathways to poor anticoagulation control. J. Thromb. Haemost. 12, 628–634 (2014).
Thomas, K. L. et al. Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure. J. Am. Heart Assoc. 2, e000200 (2013).
Yong, C. et al. Racial differences in quality of anticoagulation therapy for atrial fibrillation (from the TREAT-AF study). Am. J. Cardiol. 117, 61–68 (2016).
Connolly, S. J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139–1151 (2009).
Granger, C. B. et al. Apixaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 365, 981–992 (2011).
Patel, M. R. et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 365, 883–891 (2011).
Sur, N. B. et al. Disparities and temporal trends in the use of anticoagulation in patients with ischemic stroke and atrial fibrillation. Stroke 50, 452–1459 (2019).
Lip, G. Y. H. et al. Determinants of time in therapeutic range in patients receiving oral anticoagulants (a substudy of IMPACT). Am. J. Cardiol. 118, 1680–1684 (2016).
Golwala, H. et al. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am. Heart J. 174, 29–36 (2016).
Piccini, J. P. et al. Adherence to guideline-directed stroke prevention therapy for atrial fibrillation is achievable: first results from Get With the Guidelines-Atrial Fibrillation (GWTG-AFIB). Circulation. 139, 1497–1506 (2019).
Khalid, U. et al. Treatment of AF in American Indians and Alaska Natives. J. Am. Coll. Cardiol. 75, 2749–2750 (2020).
Patel, N. et al. Gender, race, and health insurance status in patients undergoing catheter ablation for atrial fibrillation. Am. J. Cardiol. 117, 1117–1126 (2016).
Sarraju, A., Maron, D. J. & Rodriguez, F. Under-reporting and under-representation of racial/ethnic minorities in major atrial fibrillation clinical trials. JACC Clin. Electrophysiol. 6, 739–741 (2020).
O’Neal, W. T. et al. Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation. PLoS ONE 14, e0222147 (2019).
Birman-Deych, E., Radford, M. J., Nilasena, D. S. & Gage, B. F. Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation. Stroke. 37, 1070–1074 (2006).
Kabra, R., Girotra, S. & Vaughan Sarrazin, M. Refining stroke prediction in atrial fibrillation patients by addition of African-American ethnicity to CHA2DS2-VASc score. J. Am. Coll. Cardiol. 68, 461–470 (2016).
Johnson, A. E. & Magnani, J. W. Race and stroke risk in atrial fibrillation: the limitations of a social construct. J. Am. Coll. Cardiol. 69, 906–907 (2017).
Essien, U. R. & Jackson, L. R. Race effects in CVD prediction models. J. Gen. Intern. Med. 34, 484 (2019).
Pool, L. R. et al. Longitudinal associations of neighborhood-level racial residential segregation with obesity among blacks. Epidemiology. 29, 207–214 (2018).
Buchmueller, T. C., Levinson, Z. M., Levy, H. G. & Wolfe, B. L. Effect of the affordable care act on racial and ethnic disparities in health insurance coverage. Am. J. Public Health 106, 1416–1421 (2016).
Makaroun, L. K. et al. Wealth-associated disparities in death and disability in the United States and England. JAMA Intern. Med. 177, 1745–1753 (2017).
Sholzberg, M. et al. The influence of socioeconomic status on selection of anticoagulation for atrial fibrillation. PLoS ONE 11, e0149142 (2016).
Kummer, B. R. et al. Demographic differences in catheter ablation after hospital presentation with symptomatic atrial fibrillation. J. Am. Heart Assoc. 22, e002097 (2015).
Larosa, A. R. et al. Association of household income and adverse outcomes in patients with atrial fibrillation. Heart 106, 1679–1685 (2020).
Hanchate, A. D., Schwamm, L. H., Huang, W. & Hylek, E. M. Comparison of ischemic stroke outcomes and patient and hospital characteristics by race/ethnicity and socioeconomic status. Stroke 44, 469–476 (2013).
Guhl, E. et al. Association of income and health-related quality of life in atrial fibrillation. Open Heart 6, e000974 (2019).
Cressman, A. M. et al. Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: a population-based study. Am. Heart J. 170, 133–140 (2015).
Gebreyohannes, E. A., Bhagavathula, A. S., Abebe, T. B., Seid, M. A. & Haile, K. T. In-hospital mortality among ischemic stroke patients in Gondar University Hospital: a retrospective cohort study. Stroke Res. Treat. 2019, 7275063 (2019).
Addo, J. et al. Socioeconomic status and stroke: an updated review. Stroke. 43, 1186–1191 (2012).
Soliman, E. Z., Zhang, Z. M., Judd, S., Howard, V. J. & Howard, G. Comparison of risk of atrial fibrillation among employed versus unemployed (from the REasons for Geographic and Racial Differences in Stroke study). Am. J. Cardiol. 120, 1298–1301 (2017).
Misialek, J. R. et al. Socioeconomic status and the incidence of atrial fibrillation in whites and blacks: the Atherosclerosis Risk in Communities (ARIC) study. J. Am. Heart Assoc. 3, e001159 (2014).
Shulman, E. et al. Socioeconomic status and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic whites. Clin. Cardiol. 40, 770–776 (2017).
Zöller, B., Li, X., Sundquist, J. & Sundquist, K. Neighbourhood deprivation and hospitalization for atrial fibrillation in Sweden. Europace. 15, 1119–1127 (2013).
Kivimaki, M. et al. Long working hours as a risk factor for atrial fibrllation: a multi-cohort study. Eur. Heart J. 7, 2621–2628 (2017).
Gurusamy, V. K., Brobert, G., Vora, P. & Friberg, L. Sociodemographic factors and choice of oral anticoagulant in patients with non-valvular atrial fibrillation in Sweden: a population-based cross-sectional study using data from national registers. BMC Cardiovasc. Disord. 19, 43 (2019).
Abdul-Rahim, A. H., Wong, J., McAlpine, C., Young, C. & Quinn, T. J. Associations with anticoagulation: a cross-sectional registry-based analysis of stroke survivors with atrial fibrillation. Heart. 100, 557–562 (2014).
Hernandez, I. et al. Trajectories of oral anticoagulation adherence among Medicare beneficiaries newly diagnosed with atrial fibrillation. J. Am. Heart Assoc. 8, e011427 (2019).
January, C. T. et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. J. Am. Coll. Cardiol. 74, 104–132 (2019).
Mark, D. B. et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 321, 1275–1285 (2019).
Hagengaard, L. et al. Socioeconomic differences in outcomes after hospital admission for atrial fibrillation or flutter. Eur. Hear. J. Qual. Care Clin. Outcomes 7, 295–303 (2021).
Kargoli, F. et al. Socioeconomic status as a predictor of mortality in patients admitted with atrial fibrillation. Am. J. Cardiol. 119, 1378–1381 (2017).
Harrington, R. A. et al. Call to action: rural health: a presidential advisory from the American Heart Association and American Stroke Association. Circulation. 141, e615–e644 (2020).
O’Neal, W. T., Sandesara, P. B., Kelli, H. M., Venkatesh, S. & Soliman, E. Z. Urban-rural differences in mortality for atrial fibrillation hospitalizations in the United States. Heart Rhythm. 15, 175–179 (2018).
Wu, C. et al. Impact of rural residence on warfarin use and clinical events in patients with non-valvular atrial fibrillation: a Canadian population based study. PLoS ONE 10, e0140607 (2015).
Alonso, A. et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J. Am. Heart Assoc. 2, e000102 (2013).
Lee, Y. H., Ang, T. F. A., Lin, H. C. & Chang, Y. C. Rural-urban disparities in smoking patterns among Chinese adults: a social-ecological approach. J. Ethn. Subst. Abuse https://doi.org/10.1080/15332640.2019.1633980 (2019).
Coughlin, L. N. et al. Changes in urban and rural cigarette smoking and cannabis use from 2007 to 2017 in adults in the United States. Drug Alcohol. Depend. 205, e107699 (2019).
Sardana, M. et al. Provider-level variation in smoking cessation assistance provided in the cardiology clinics: insights from the NCDR PINNACLE registry. J. Am. Heart Assoc. 8, e011412 (2019).
Frewen, J. et al. Factors that influence awareness and treatment of atrial fibrillation in older adults. QJM 106, 415–424 (2013).
Lunde, E. D. et al. Socioeconomic position and risk of atrial fibrillation: a nationwide Danish cohort study. J. Epidemiol. Community Health. 74, 7–13 (2020).
McAlister, F. A., Garrison, S., Kosowan, L., Ezekowitz, J. A. & Singer, A. Use of direct oral anticoagulants in Canadian primary care practice 2010–2015: a cohort study from the Canadian Primary Care Sentinel Surveillance Network. J. Am. Heart Assoc. 7, e007603 (2018).
Ruiz-Pérez, I., Bastos, Á., Serrano-Ripoll, M. J. & Ricci-Cabello, I. Effectiveness of interventions to improve cardiovascular healthcare in rural areas: a systematic literature review of clinical trials. Prev. Med. 199, 131–144 (2019).
Roshanov, P. S. et al. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ 346, f657 (2013).
Arts, D. L., Abu-Hanna, A., Medlock, S. K. & Van Weert, H. C. P. M. Effectiveness and usage of a decision support system to improve stroke prevention in general practice: a cluster randomized controlled trial. PLoS ONE 12, e0170974 (2017).
Cox, J. L. et al. Integrated management program advancing community treatment of atrial fibrillation (IMPACT-AF): a cluster randomized trial of a computerized clinical decision support tool. Am. Heart J. 224, 35–46 (2020).
O’Brien, D. T., Farrell, C. & Welsh, B. C. Broken (windows) theory: a meta-analysis of the evidence for the pathways from neighborhood disorder to resident health outcomes and behaviors. Soc. Sci. Med. 228, 272–292 (2019).
Arcaya, M. C. et al. Research on neighborhood effects on health in the United States: a systematic review of study characteristics. Soc. Sci. Med. 168, 16–29 (2016).
Wang, K. et al. Relationship of neighborhood greenness to heart disease in 249 405 US Medicare beneficiaries. J. Am. Heart Assoc. 8, e010258 (2019).
Carlsson, A. C., Wändell, P., Gasevic, D., Sundquist, J. & Sundquist, K. Neighborhood deprivation and warfarin, aspirin and statin prescription – a cohort study of men and women treated for atrial fibrillation in Swedish primary care. Int. J. Cardiol. 187, 547–552 (2015).
Wändell, P., Carlsson, A. C., Gasevic, D., Sundquist, J. & Sundquist, K. Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: a cohort study of patients treated in primary care in Sweden. Int. J. Cardiol. 202, 776–781 (2016).
Bennett, J. E. et al. Particulate matter air pollution and national and county life expectancy loss in the USA: a spatiotemporal analysis. PLoS Med. 16, e10002856 (2019).
Banzhaf, S., Ma, L. & Timmins, C. Environmental justice: the economics of race, place, and pollution. J. Econ. Perspect. 33, 185–208 (2019).
Monrad, M. et al. Long-term exposure to traffic-related air pollution and risk of incident atrial fibrillation: a cohort study. Env. Health Perspect. 125, 422–427 (2017).
Shin, S. et al. Ambient air pollution and the risk of atrial fibrillation and stroke: a population-based cohort study. Env. Health Perspect. 127, e870009 (2019).
Kim, I.-S. et al. Long-term exposure of fine particulate matter air pollution and incident atrial fibrillation in the general population: a nationwide cohort study. Int. J. Cardiol. 283, 178–183 (2019).
Monrad, M. et al. Residential exposure to traffic noise and risk of incident atrial fibrillation: a cohort study. Env. Int. 92–93, 457–463 (2016).
Rhinehart, Z. J. et al. Association of fine particulate matter and risk of stroke in patients with atrial fibrillation. JAMA Netw. Open 3, e2011760 (2020).
Institute of Medicine. Health Literacy: A Prescription to End Confusion (National Academies Press, 2004).
US Department of Health and Human Services. HHS.gov. Civil Rights https://www.hhs.gov/civil-rights/for-individuals/special-topics/limited-english-proficiency/guidance-federal-financial-assistance-recipients-title-vi/index.html (2013).
Kutner M., Greenberg E., Jin Y., Paulsen C. The Health Literacy of America’s Adults: Results from the 2003 National Assessment of Adult Literacy (NCES 2006-483) (US Department of Education, 2006).
Ryan C. Language use in the United States: 2011. census.gov https://www2.census.gov/library/publications/2013/acs/acs-22/acs-22.pdf (2013).
The Migration Observatory. English language use and proficiency of migrants in the UK. https://migrationobservatory.ox.ac.uk/resources/briefings/english-language-use-and-proficiency-of-migrants-in-the-uk/ (2019).
Obamiro, K. O., Chalmers, L., Lee, K., Bereznicki, B. J. & Bereznicki, L. R. E. Anticoagulation knowledge in patients with atrial fibrillation: an Australian survey. Int. J. Clin. Pract. 72, e13072 (2018).
Konstantinos, N. A. et al. Health literacy and atrial fibrillation: relevance and future directions for patient-centred care. Eur. Cardiol. Rev. 12, 52–57 (2017).
Reading, S. R. et al. Health literacy and awareness of atrial fibrillation. J. Am. Heart Assoc. 6, e005128 (2017).
Fang, M. C., Panguluri, P., Machtinger, E. L. & Schillinger, D. Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: implications for health communication. Patient Educ. Couns. 95, 403–410 (2009).
Aliot, E. et al. An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality. Europace 12, 626–633 (2010).
Diug, B. et al. The unrecognized psychosocial factors contributing to bleeding risk in warfarin therapy. Stroke 42, 2866–2871 (2011).
Rodriguez, F. et al. Limited English proficient patients and time spent in therapeutic range in a warfarin anticoagulation clinic. J. Am. Heart Assoc. 2, e00017 (2013).
Schillinger, D. The intersections between social determinants of health, health literacy, and health disparities. Stud. Health Technol. Inform. 269, 22–41 (2020).
Hindricks et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 5, 373–498 (2021).
Pérez-Stable, E. J. & El-Toukhy, S. Communicating with diverse patients: how patient and clinician factors affect disparities. Patient Educ. Couns. 101, 2186–2194 (2018).
Seaburg, L. et al. Shared decision making in atrial fibrillation: where we are and where we should be going. Circulation 129, 704–710 (2014).
Pantell, M. et al. Social isolation: a predictor of mortality comparable to traditional clinical risk factors. Am. J. Public Health 103, 2056–2062 (2013).
Garg, P. K. et al. Associations of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation: the Atherosclerosis Risk in Communities Study. Eur. J. Prev. Cardiol. 28, 633–640 (2021).
Chang, S.-C. et al. Social integration and reduced risk of coronary heart disease in women: the role of lifestyle behaviors. Circ. Res. 120, 1927–1937 (2017).
Laugesen, K. et al. Social isolation and all-cause mortality: a population-based cohort study in Denmark. Sci. Rep. 8, 4731 (2018).
Valtorta, N. K., Kanaan, M., Gilbody, S., Ronzi, S. & Hanratty, B. Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies. Heart. 102, 1009–1016 (2016).
Wang, W. et al. Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: the SAGE-AF study. J. Cardiovasc. Electrophysiol. 30, 2508–2515 (2019).
Westcott, S. K. et al. Relationship between psychosocial stressors and atrial fibrillation in women over 45 years of age. Am. J. Cardiol. 122, 1684–1687 (2018).
Kivimaki, M. & Steptoe, A. Effects of stress on the development and progression of cardiovascular disease. Nat. Rev. Cardiol. 15, 215–229 (2017).
Smith, B. & Magnani, J. W. New technologies, new disparities: the interesection of electronic health and digital health literacy. Int. J. Cardiol. 292, 280–282 (2019).
Ayyaswami, V. et al. Mobile health applications for atrial fibrillation: a readability and quality assessment. Int. J. Cardiol. 15, 288–293 (2019).
Kincaid, J. P., Fishburne, R. P. Jr., Rogers, R. L. & Chissom, B. S. Derivation of new readability formulas (Automated Readability Index, Fog Count and Flesch Reading Ease Formula) for Navy Enlisted Personnel. (Institute for Simulation and Training, University of Central Florida, 1975)
Waring, M. E. Characteristics associated with Facebook use and interest in digital disease support among older adults with atrial fibrillation: cross-sectional analysis of baseline data from the Systematic Assessment of Geriatric Elements in Atrial Fibrillation (SAGE-AF) cohort. JMIR Cardio. 3, e15320 (2019).
Ferguson, C. et al. The caregiver role in thromboprophylaxis management in atrial fibrillation: a literature review. Eur. J. Cardiovasc. Nurs. 14, 98–107 (2015).
Connolly, S. J. et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N. Engl. J. Med. 360, 2066–2078 (2009).
Connolly, S. J. et al. Apixaban in patients with atrial fibrillation. N. Engl. J. Med. 364, 806–817 (2011).
Giugliano, R. P. et al. Edoxaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 369, 2093–2104 (2013).
Holmes, D. R. et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J. Am. Coll. Cardiol. 64, 1–12 (2014).
Douketis, J. D. et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N. Engl. J. Med. 373, 823–833 (2015).
Cannon, C. P. et al. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N. Engl. J. Med. 377, 1513–1524 (2017).
Ezekowitz, M. D. et al. Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial. Eur. Heart J. 39, 2959–2971 (2018).
Perez, M. V. et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N. Engl. J. Med. 381, 1909–1917 (2019).
Lopes, R. D. et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N. Engl. J. Med. 380, 1509–1524 (2019).
Packer, D. L. et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 321, 1261–1274 (2019).
U.R.E. has received funding from the Department of Veterans Affairs VISN 4 Competitive Career Development Fund and Health Services Research and Development Service CDA-20-049. J.K. has received funding from the Marie Sklodowska-Curie Actions under the European Commission’s Horizon 2020 research and innovation programme (grant agreement no. 838259). E.J.B. is supported by grants 2R01 HL092577, 1R01 HL141434, 2U54HL120163, 1R01AG066010, 1R01AG066914, 2U54HL120163 and AHA 18SFRN34110082. J.W.M. is supported by grants R33HL144669 and R01HL143010. The other authors declare no competing interests.
Peer review information
Nature Reviews Cardiology thanks the anonymous reviewers for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- Readability score
A score indicating how difficult a text in English is to understand; it can be graded according to US school and higher education level: 5th grade (very easy; easily understood by students aged 11 years), 6th grade (easy; conversational English for consumers), 7th grade (fairly easy), 8th–9th grade (plain English; easily understood by students aged 13–15 years), 10th–12th grade (fairly difficult), College (difficult), College graduate (very difficult) and Professional (extremely difficult).
- Allostatic load
The ‘wear and tear’ on the body that accumulates as an individual is exposed to repeated or chronic stress.
About this article
Cite this article
Essien, U.R., Kornej, J., Johnson, A.E. et al. Social determinants of atrial fibrillation. Nat Rev Cardiol 18, 763–773 (2021). https://doi.org/10.1038/s41569-021-00561-0
Association Between Neighborhood-Level Poverty and Incident Atrial Fibrillation: a Retrospective Cohort Study
Journal of General Internal Medicine (2022)